LATEST REPORT    Details
latest report
Card image
Global Biodefense Market 2020-2030 by Product (Vaccines, Detection Devices, Antibiotics, Masks), Sales Channel, Application (Military, Civilian), and Region: Trend Forecast and Growth Opportunity
  • Category:
    ICT & Media
  • Published on:
    20 June, 2020
  • Pages:
    165
  • Formats:
    pdf excel cd
  • Report Code:
    PMR - 837321
  • Publisher:
    GMD
Card image

Global biodefense market will reach $15.85 billion by 2030, growing by 6.2% annually over 2020-2030 owing to the rising need for military and civilian vaccines and equipment against diseases including COVID-19 pandemic.
Highlighted with 84 tables and 73 figures, this 165-page report ?Global Biodefense Market 2020-2030 by Product (Vaccines, Detection Devices, Antibiotics, Masks), Sales Channel, Application (Military, Civilian), and Region: Trend Forecast and Growth Opportunity? is based on a comprehensive research of the entire global biodefense market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
? Market Structure
? Growth Drivers
? Restraints and Challenges
? Emerging Product Trends & Market Opportunities
? Porter?s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global biodefense market in every aspect of the classification from perspectives of Product, Sales Channel, Application, and Region.
Based on Product, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Vaccines
? Anthrax
? Smallpox
? Botulism
? Nuclear/Radiation
? E-Bola
? Zika
? Other Vaccines
Biothreat Detection Devices
? Detectors/Triggering Devices
? Assays and Reagents
? Samplers
? Identifiers
Antibiotics
Masks
Other Products
Based on Sales Channel, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
? Online Sales
? Offline Sales
Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
? Military
? Civilian
Geographically, the following regions together with the listed national/local markets are fully investigated:
? APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
? Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
? North America (U.S., Canada, and Mexico)
? South America (Brazil, Chile, Argentina, Rest of South America)
? RoW (Saudi Arabia, UAE, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product, Sales Channel, Application over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global biodefense market are assayed quantitatively and qualitatively through GMD?s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Achaogen, Inc.
Alexeter Technologies LLC
Alnylam Pharmaceuticals, Inc.
Altimmune, Inc.
Bavarian Nordic AS
BioFactura, Inc.
Cleveland Biolabs, Inc.
Dynavax Technologies Inc
Dynport Vaccine Company LLC (DVC)
Elusys Therapeutics, Inc.
Emergent BioSolutions Inc
General Dynamics Corp.
GlaxoSmithKline Plc
Ichor Medical Systems
Mediimmune (AstraZeneca)
Nanotherapeutics, Inc.
Ology Bioscience
PathSensors Inc
Pluristem Therapeutics
Sanofi Pasteur Ltd.
SIGA Technologies, Inc.
Soligenix, Inc.
Xoma Corporation
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.2 Major Growth Drivers 21
2.3 Market Restraints and Challenges 24
2.4 Emerging Opportunities and Market Trends 27
2.5 Porter?s Fiver Forces Analysis 31
3 Segmentation of Global Market by Product 35
3.1 Market Overview by Product 35
3.2 Vaccines 37
3.2.1 Anthrax 40
3.2.2 Smallpox 41
3.2.3 Botulism 42
3.2.4 Nuclear/Radiation 43
3.2.5 E-Bola 44
3.2.6 Zika 45
3.2.7 Other Vaccines 46
3.3 Biothreat Detection Devices 47
3.4 Antibiotics 49
3.5 Masks 50
3.6 Other Products 51
4 Segmentation of Global Market by Sales Channel 52
4.1 Market Overview by Sales Channel 52
4.2 Online Sales 54
4.3 Offline Sales 55
5 Segmentation of Global Market by Application 56
5.1 Market Overview by Application 56
5.2 Military 58
5.3 Civilian 59
6 Segmentation of Global Market by Region 60
6.1 Geographic Market Overview 2019-2030 60
6.2 North America Market 2019-2030 by Country 64
6.2.1 Overview of North America Market 64
6.2.2 U.S. 68
6.2.3 Canada 72
6.2.4 Mexico 74
6.3 European Market 2019-2030 by Country 76
6.3.1 Overview of European Market 76
6.3.2 Germany 80
6.3.3 UK 82
6.3.4 France 84
6.3.5 Spain 86
6.3.6 Italy 88
6.3.7 Russia 90
6.3.8 Rest of European Market 92
6.4 Asia-Pacific Market 2019-2030 by Country 94
6.4.1 Overview of Asia-Pacific Market 94
6.4.2 Japan 98
6.4.3 China 101
6.4.4 Australia 103
6.4.5 India 105
6.4.6 South Korea 107
6.4.7 Rest of APAC Region 109
6.5 South America Market 2019-2030 by Country 111
6.5.1 Argentina 114
6.5.2 Brazil 116
6.5.3 Chile 118
6.5.4 Rest of South America Market 120
6.6 Rest of World Market 2019-2030 by Country 121
6.6.1 UAE 124
6.6.2 Saudi Arabia 126
6.6.3 South Africa 128
6.6.4 Other National Markets 130
7 Competitive Landscape 131
7.1 Overview of Key Vendors 131
7.2 New Product Launch, Partnership, Investment, and M&A 134
7.3 Company Profiles 135
Achaogen, Inc. 135
Alexeter Technologies LLC 137
Alnylam Pharmaceuticals, Inc. 138
Altimmune, Inc. 139
Bavarian Nordic AS 140
BioFactura, Inc. 141
Cleveland Biolabs, Inc. 142
Dynavax Technologies Inc 143
Dynport Vaccine Company LLC (DVC) 144
Elusys Therapeutics, Inc. 145
Emergent BioSolutions Inc 146
General Dynamics Corp. 147
GlaxoSmithKline Plc 148
Ichor Medical Systems 149
Mediimmune (AstraZeneca) 150
Nanotherapeutics, Inc. 151
Ology Bioscience 152
PathSensors Inc 153
Pluristem Therapeutics 154
Sanofi Pasteur Ltd. 155
SIGA Technologies, Inc. 156
Soligenix, Inc. 157
Xoma Corporation 158
8 Investing in Global Market: Risk Assessment and Management 159
8.1 Risk Evaluation of Global Market 159
8.2 Critical Success Factors (CSFs) 162
Related Reports and Products 165

Table 1. Snapshot of Global Biodefense Market, 2019-2030 19
Table 2. Main Product Trends and Market Opportunities in Global Biodefense Market 27
Table 3. Global Biodefense Market by Product, 2019-2030, $ mn 35
Table 4. Global Biodefense Market: Vaccines by Application, 2019-2030, $ mn 38
Table 5. List of Biodefense Vaccine Pipelines 39
Table 6. Global Biodefense Market: Vaccines Biothreat Detection Devices by Type, 2019-2030, $ mn 48
Table 7. Global Biodefense Market by Sales Channel, 2019-2030, $ mn 52
Table 8. Global Market by Application, 2019-2030, $ mn 56
Table 9. Global Biodefense Market by Region, 2019-2030, $ mn 61
Table 10. Leading National Biodefense Market, 2019 and 2030, $ mn 63
Table 11. North America Biodefense Market by Country, 2019-2030, $ mn 66
Table 12. U.S. Biodefense Market by Product, 2019-2030, $ mn 70
Table 13. U.S. Biodefense Market by Sales Channel, 2019-2030, $ mn 70
Table 14. U.S. Biodefense Market by Application, 2019-2030, $ mn 70
Table 15. Canada Biodefense Market by Product, 2019-2030, $ mn 73
Table 16. Canada Biodefense Market by Sales Channel, 2019-2030, $ mn 73
Table 17. Canada Biodefense Market by Application, 2019-2030, $ mn 73
Table 18. Mexico Biodefense Market by Product, 2019-2030, $ mn 75
Table 19. Mexico Biodefense Market by Sales Channel, 2019-2030, $ mn 75
Table 20. Mexico Biodefense Market by Application, 2019-2030, $ mn 75
Table 21. Europe Biodefense Market by Country, 2019-2030, $ mn 79
Table 22. Germany Biodefense Market by Product, 2019-2030, $ mn 81
Table 23. Germany Biodefense Market by Sales Channel, 2019-2030, $ mn 81
Table 24. Germany Biodefense Market by Application, 2019-2030, $ mn 81
Table 25. UK Biodefense Market by Product, 2019-2030, $ mn 83
Table 26. UK Biodefense Market by Sales Channel, 2019-2030, $ mn 83
Table 27. UK Biodefense Market by Application, 2019-2030, $ mn 83
Table 28. France Biodefense Market by Product, 2019-2030, $ mn 85
Table 29. France Biodefense Market by Sales Channel, 2019-2030, $ mn 85
Table 30. France Biodefense Market by Application, 2019-2030, $ mn 85
Table 31. Spain Biodefense Market by Product, 2019-2030, $ mn 87
Table 32. Spain Biodefense Market by Sales Channel, 2019-2030, $ mn 87
Table 33. Spain Biodefense Market by Application, 2019-2030, $ mn 87
Table 34. Italy Biodefense Market by Product, 2019-2030, $ mn 89
Table 35. Italy Biodefense Market by Sales Channel, 2019-2030, $ mn 89
Table 36. Italy Biodefense Market by Application, 2019-2030, $ mn 89
Table 37. Russia Biodefense Market by Product, 2019-2030, $ mn 91
Table 38. Russia Biodefense Market by Sales Channel, 2019-2030, $ mn 91
Table 39. Russia Biodefense Market by Application, 2019-2030, $ mn 91
Table 40. Biodefense Market in Rest of Europe by Country, 2019-2030, $ mn 93
Table 41. APAC Biodefense Market by Country, 2019-2030, $ mn 96
Table 42. Japan Biodefense Market by Product, 2019-2030, $ mn 100
Table 43. Japan Biodefense Market by Sales Channel, 2019-2030, $ mn 100
Table 44. Japan Biodefense Market by Application, 2019-2030, $ mn 100
Table 45. China Biodefense Market by Product, 2019-2030, $ mn 102
Table 46. China Biodefense Market by Sales Channel, 2019-2030, $ mn 102
Table 47. China Biodefense Market by Application, 2019-2030, $ mn 102
Table 48. Australia Biodefense Market by Product, 2019-2030, $ mn 104
Table 49. Australia Biodefense Market by Sales Channel, 2019-2030, $ mn 104
Table 50. Australia Biodefense Market by Application, 2019-2030, $ mn 104
Table 51. India Biodefense Market by Product, 2019-2030, $ mn 106
Table 52. India Biodefense Market by Sales Channel, 2019-2030, $ mn 106
Table 53. India Biodefense Market by Application, 2019-2030, $ mn 106
Table 54. South Korea Biodefense Market by Product, 2019-2030, $ mn 108
Table 55. South Korea Biodefense Market by Sales Channel, 2019-2030, $ mn 108
Table 56. South Korea Biodefense Market by Application, 2019-2030, $ mn 108
Table 57. Biodefense Market in Rest of APAC by Country, 2019-2030, $ mn 110
Table 58. South America Biodefense Market by Country, 2019-2030, $ mn 113
Table 59. Argentina Biodefense Market by Product, 2019-2030, $ mn 115
Table 60. Argentina Biodefense Market by Sales Channel, 2019-2030, $ mn 115
Table 61. Argentina Biodefense Market by Application, 2019-2030, $ mn 115
Table 62. Brazil Biodefense Market by Product, 2019-2030, $ mn 117
Table 63. Brazil Biodefense Market by Sales Channel, 2019-2030, $ mn 117
Table 64. Brazil Biodefense Market by Application, 2019-2030, $ mn 117
Table 65. Chile Biodefense Market by Product, 2019-2030, $ mn 119
Table 66. Chile Biodefense Market by Sales Channel, 2019-2030, $ mn 119
Table 67. Chile Biodefense Market by Application, 2019-2030, $ mn 119
Table 68. RoW Biodefense Market by Country, 2019-2030, $ mn 123
Table 69. UAE Biodefense Market by Product, 2019-2030, $ mn 125
Table 70. UAE Biodefense Market by Sales Channel, 2019-2030, $ mn 125
Table 71. UAE Biodefense Market by Application, 2019-2030, $ mn 125
Table 72. Saudi Arabia Biodefense Market by Product, 2019-2030, $ mn 127
Table 73. Saudi Arabia Biodefense Market by Sales Channel, 2019-2030, $ mn 127
Table 74. Saudi Arabia Biodefense Market by Application, 2019-2030, $ mn 127
Table 75. South Africa Biodefense Market by Product, 2019-2030, $ mn 129
Table 76. South Africa Biodefense Market by Sales Channel, 2019-2030, $ mn 129
Table 77. South Africa Biodefense Market by Application, 2019-2030, $ mn 129
Table 78. Achaogen, Inc.: Company Snapshot 135
Table 79. Achaogen, Inc.: Business Segmentation 135
Table 80. Achaogen, Inc.: Product Portfolio 136
Table 81. Achaogen, Inc.: Revenue, 2016-2018, $ mn 136
Table 82. Achaogen, Inc.: Recent Developments 136
Table 83. Risk Evaluation for Investing in Global Market, 2019-2030 160
Table 84. Critical Success Factors and Key Takeaways 163